Sleep-related breathing disorders in facioscapulohumeral dystrophy.


Journal

Sleep & breathing = Schlaf & Atmung
ISSN: 1522-1709
Titre abrégé: Sleep Breath
Pays: Germany
ID NLM: 9804161

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 12 01 2019
accepted: 08 04 2019
revised: 04 04 2019
pubmed: 27 4 2019
medline: 3 11 2020
entrez: 27 4 2019
Statut: ppublish

Résumé

Severe manifestations of facioscapulohumeral dystrophy (FSHD) may be associated with sleep-disordered breathing (SDB), including obstructive sleep apnea (OSA) and nocturnal hypoventilation (NH), but prevalence data are scarce. In patients with respiratory muscle weakness, detection of NH can be facilitated by transcutaneous capnometry, but respective data derived from FSHD patients have not yet been published. We collected sleep studies and capnometry recordings from 31 adult patients with genetically confirmed FSHD who were admitted to our sleep laboratory for first-ever evaluation of sleep-related breathing. Indications for admission included non-restorative sleep, morning headache, or excessive daytime sleepiness. In addition, sleep studies were initiated if symptoms or signs of respiratory muscle weakness were present. Thirty-one subjects with insomnia served as controls for comparison of respiratory measures during sleep. In the FSHD group, 17/31 (55%) patients showed OSA and 8 (26%) had NH. NH would have been missed in 7/8 patients if only oximetry criteria of hypoventilation had been applied. Capnography results were correlated with disease severity as reflected by the Clinical Severity Score (CSS). Non-invasive ventilation (NIV) was started in 6 patients with NH and 3 individuals with OSA. Nocturnal continuous positive airway pressure was administered to 2 patients, and positional therapy was sufficient in 4 individuals. In patients initiated on NIV, nocturnal gas exchange already improved in the first night of treatment. SDB is common in adult patients with FSHD complaining of sleep-related symptoms. It may comprise OSA, NH, and most often, the combination of both. Sleep-related hypercapnia is associated with disease severity. Transcutaneous capnometry is superior to pulse oximetry for detection of NH.

Identifiants

pubmed: 31025273
doi: 10.1007/s11325-019-01843-1
pii: 10.1007/s11325-019-01843-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

899-906

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Lemmers RJLF, Miller DG, van der Maarel SM. Facioscapulohumeral muscular dystrophy. 1999 Mar 8 [Updated 2014 Mar 20]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1443/
Statland J, Tawil R (2014) Facioscapulohumeral muscular dystrophy. Neurol Clin 32:721–728. https://doi.org/10.1016/j.ncl.2014.04.003
doi: 10.1016/j.ncl.2014.04.003 pubmed: 25037087 pmcid: 4239655
Jordan B, Eger K, Koesling S, Zierz S (2011) Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. J Neurol 258:866–873. https://doi.org/10.1007/s00415-010-5858-z
doi: 10.1007/s00415-010-5858-z pubmed: 21165637
Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, Jones K, Krishnamurthi R, Feigin V (2014) Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology 43:259–268. https://doi.org/10.1159/000369343
doi: 10.1159/000369343 pubmed: 25532075
Fisher J, Upadhyaya M (1997) Molecular genetics of facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord 7:655–662. https://doi.org/10.1016/S0960-8966(96)00400-2
doi: 10.1016/S0960-8966(96)00400-2
Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B, Piazzo N, Servidei S, Vigneti E, Pasceri V, Silvestri G, Mirabella M, Mangiola F, Tonali P, Felicetti L (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45:751–757. https://doi.org/10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M
doi: 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M pubmed: 10360767
Larsen M, Rost S, El Hajj N, Ferbert A, Deschauer M, Walter MC et al (2015) Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Hum Genet 23:808–816. https://doi.org/10.1038/ejhg.2014.191
doi: 10.1038/ejhg.2014.191 pubmed: 25370034
LoMauro A, D’Angelo MG, Aliverti A (2017) Sleep disordered breathing in Duchenne muscular dystrophy. Curr Neurol Neurosci Rep 17:44. https://doi.org/10.1007/s11910-017-0750-1
doi: 10.1007/s11910-017-0750-1 pubmed: 28397169
Smith PEM, Edwards RHT, Calverley PMA (1989) Ventilation and breathing pattern during sleep in Duchenne muscular dystrophy. Chest 96:1346–1351. https://doi.org/10.1378/chest.96.6.1346
doi: 10.1378/chest.96.6.1346 pubmed: 2582842
Bianchi MLL, Losurdo A, Di Blasi C, Santoro M, Masciullo M, Conte G et al (2014) Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2. Sleep Breath 18:579–589. https://doi.org/10.1007/s11325-013-0921-5
doi: 10.1007/s11325-013-0921-5 pubmed: 24310756
Poppe M, Cree L, Bourke J, Eagle M, Anderson LVB, Birchall D, Brockington M, Buddles M, Busby M, Muntoni F, Wills A, Bushby K (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60:1246–1251. https://doi.org/10.1212/01.WNL.0000058902.88181.3D
doi: 10.1212/01.WNL.0000058902.88181.3D pubmed: 12707425
Fayssoil A, Ogna A, Chaffaut C, Chevret S, Guimarães-Costa R, Leturcq F, Wahbi K, Prigent H, Lofaso F, Nardi O, Clair B, Behin A, Stojkovic T, Laforet P, Orlikowski D, Annane D (2016) Natural history of cardiac and respiratory involvement, prognosis and predictive factors for long-term survival in adult patients with limb girdle muscular dystrophies type 2C and 2D. PLoS One 11:e0153095. https://doi.org/10.1371/journal.pone.0153095
doi: 10.1371/journal.pone.0153095 pubmed: 27120200 pmcid: 4847860
Boentert M, Wenninger S, Sansone VAA (2017) Respiratory involvement in neuromuscular disorders. Curr Opin Neurol 30:529–537. https://doi.org/10.1097/WCO.0000000000000470
doi: 10.1097/WCO.0000000000000470 pubmed: 28562381
Wohlgemuth M, Van Der Kooi EL, Van Kesteren RG, Van Der Maarel SM, Padberg GW (2004) Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 63:176–178. https://doi.org/10.1212/01.WNL.0000133126.86377.E8
doi: 10.1212/01.WNL.0000133126.86377.E8 pubmed: 15249635
Moreira S, Wood L, Smith D, Marini-Bettolo C, Guglieri M, McMacken G, Bailey G, Mayhew A, Muni-Lofra R, Eglon G, Williams M, Straub V, Lochmüller H, Evangelista T (2017) Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy. J Neurol 264:1271–1280. https://doi.org/10.1007/s00415-017-8525-9
doi: 10.1007/s00415-017-8525-9 pubmed: 28550484 pmcid: 5486574
Della Marca G, Frusciante R, Dittoni S, Vollono C, Buccarella C, Iannaccone E, Rossi M, Scarano E, Pirronti T, Cianfoni A, Mazza S, Tonali PA, Ricci E (2009) Sleep disordered breathing in facioscapulohumeral muscular dystrophy. J Neurol Sci 285:54–58. https://doi.org/10.1016/j.jns.2009.05.014
doi: 10.1016/j.jns.2009.05.014 pubmed: 19501370
Boentert M, Glatz C, Helmle C, Okegwo A, Young P (2018) Prevalence of sleep apnoea and capnographic detection of nocturnal hypoventilation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 89:418–424. https://doi.org/10.1136/jnnp-2017-316515
doi: 10.1136/jnnp-2017-316515 pubmed: 29054915
Georges M, Nguyen-Baranoff D, Griffon L, Foignot C, Bonniaud P, Camus P, Pepin JL, Rabec C (2016) Usefulness of transcutaneous PCO2 to assess nocturnal hypoventilation in restrictive lung disorders. Respirology 21:1300–1306. https://doi.org/10.1111/resp.12812
doi: 10.1111/resp.12812 pubmed: 27185178
Ogna A, Quera Salva MA, Prigent H, Mroue G, Vaugier I, Annane D, Lofaso F, Orlikowski D (2016) Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature. Sleep Breath 20:575–581. https://doi.org/10.1007/s11325-015-1247-2
doi: 10.1007/s11325-015-1247-2 pubmed: 26338464
The AASM Manual for the scoring of sleep and associated events n.d.
Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM, American Academy of Sleep Medicine (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. J Clin Sleep Med 8:597–619. https://doi.org/10.5664/jcsm.2172
doi: 10.5664/jcsm.2172 pubmed: 23066376 pmcid: 3459210
Storre JH, Magnet FS, Dreher M, Windisch W (2011) Transcutaneous monitoring as a replacement for arterial PCO(2) monitoring during nocturnal non-invasive ventilation. Respir Med 105:143–150. https://doi.org/10.1016/j.rmed.2010.10.007
doi: 10.1016/j.rmed.2010.10.007 pubmed: 21030230
Windisch W, Dreher M, Geiseler J, Siemon K, Brambring J, Dellweg D, Grolle B, Hirschfeld S, Köhnlein T, Mellies U, Rosseau S, Schönhofer B, Schucher B, Schütz A, Sitter H, Stieglitz S, Storre J, Winterholler M, Young P, Walterspacher S, für die Leitliniengruppe “Nichtinvasive und invasive Beatmung als Therapie der chronischen respiratorischen Insuffizienz” (2017) Guidelines for non-invasive and invasive home mechanical ventilation for treatment of chronic respiratory failure - update 2017. Pneumologie 71:722–795. https://doi.org/10.1055/s-0043-118040
doi: 10.1055/s-0043-118040 pubmed: 29139100
Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation–a consensus conference report. Chest 1999;116:521–34. https://doi.org/10.1378/chest.116.2.521 .
Nardi J, Prigent H, Adala A, Bohic M, Lebargy F, Quera-Salva MA, Orlikowski D, Lofaso F (2012) Nocturnal oximetry and transcutaneous carbon dioxide in home-ventilated neuromuscular patients. Respir Care 57:1425–1430. https://doi.org/10.4187/respcare.01658
doi: 10.4187/respcare.01658 pubmed: 22348449
Janssens JP, Borel JC, Pepin JL, groupe Somno VNI (2014) Nocturnal monitoring of home non-invasive ventilation: contribution of simple tools such as pulse-oximetry, capnography, built-in ventilator software and autonomic markers of sleep fragmentation. Rev Mal Respir 31:107–118. https://doi.org/10.1016/j.rmr.2013.08.003
doi: 10.1016/j.rmr.2013.08.003 pubmed: 24602678
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545. https://doi.org/10.1093/sleep/14.6.540
doi: 10.1093/sleep/14.6.540 pubmed: 1798888
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213. https://doi.org/10.1016/0165-1781(89)90047-4
doi: 10.1016/0165-1781(89)90047-4 pubmed: 2748771
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123. https://doi.org/10.1001/archneur.1989.00520460115022
doi: 10.1001/archneur.1989.00520460115022 pubmed: 2803071
Windisch W, Walterspacher S, Siemon K, Geiseler J, Sitter H (2010) Guidelines for non-invasive and invasive mechanical ventilation for treatment of chronic respiratory failure. Published by the German Society for Pneumology (DGP). Pneumologie 64:640–652. https://doi.org/10.1055/s-0030-1255558
doi: 10.1055/s-0030-1255558 pubmed: 20799159
Boentert M, Brenscheidt I, Glatz C, Young P (2015) Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis. J Neurol 262:2073–2082. https://doi.org/10.1007/s00415-015-7822-4
doi: 10.1007/s00415-015-7822-4 pubmed: 26076745
Annane D, Orlikowski D, Chevret S (2014) Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev 12:CD001941. https://doi.org/10.1002/14651858.CD001941.pub3
doi: 10.1002/14651858.CD001941.pub3
Boentert M, Dräger B, Glatz C, Young P (2016) Sleep-disordered breathing and effects of noninvasive ventilation in patients with late-onset Pompe disease. J Clin Sleep Med 12:1623–1632. https://doi.org/10.5664/jcsm.6346
doi: 10.5664/jcsm.6346 pubmed: 27568896 pmcid: 5155202

Auteurs

Maya Runte (M)

Department of Neurology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Muenster, Germany.

Jens Spiesshoefer (J)

Department of Neurology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Muenster, Germany.

Anna Heidbreder (A)

Department of Neurology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Muenster, Germany.

Michael Dreher (M)

Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany.

Peter Young (P)

Medical Park Klinik Reithofpark, Neurology, Bad Feilnbach, Germany.

Tobias Brix (T)

Institute of Medical Informatics, University of Muenster, Muenster, Germany.

Matthias Boentert (M)

Department of Neurology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Muenster, Germany. matthias.boentert@ukmuenster.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH